Dr. Elizabeth Nabel Joins Moderna’s Board Of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™, announced today that Elizabeth (Betsy) Nabel, M.D., President of Harvard-affiliated Brigham and Women’s Health Care (BWHC) has been appointed to the company’s Board of Directors.

Back to news